Halozyme Therapeutics stock hits all-time high at 125.53 USD
Reported by Investing.com · investing.com ·
Story context
What to watch: Potential opportunity in Healthcare & Pharma — evaluate fundamentals before acting.
Latest session change: $HALO +0.72%
How this was labelled
Investing.com published it, and Wook filed it under Healthcare & Pharma. It reads bullish at medium severity because of “high” and “all-time high” in the wording, with nothing on the bearish side to offset them. It was matched to $HALO. The publisher gave no preview text, and nothing has been written in to fill the gap.
When it landed
It landed while New York was open, so the session move beside it may include the reaction.
Where the price is
$HALO last traded at $125.44, +0.72% on the session. That is 0.4% below its 52-week high of $125.90 and 105% above its low of $61.23 — within a tenth of its 52-week high. The year's range spans 106% from low to high: a very wide band for one year, the kind of volatility where large swings are routine. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 1 story about $HALO in the last 30 days, 1 of them this week. At the 30-day pace you would expect about 0 a week, so this week is running well ahead of normal — something has drawn extra attention. Across those stories the wording ran 100% bullish, 0% neutral and 0% bearish; this one reads bullish, so it sits with the majority of the run. This is the only one from Investing.com; the rest came from other outlets. 12 of them are listed beside this one.
The backdrop
Healthcare stories tend to turn on approvals, trial data and pricing: an FDA decision or a trial readout can move a single drugmaker sharply, while drug-pricing policy moves the whole group. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
What is already on the calendar
$HALO earnings in 10 days. These were scheduled before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company will arrive soon.
Where to look next
The $HALO page has the full chart, the filings and the valuation model behind these figures. Because one outlet dominates the coverage, reading another outlet on the same story is the quickest check on whether it is being confirmed or just repeated. Wook AI, above, can pull live figures and do the math — how far $HALO is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on October 23, 2026. $HALO has moved -0.19% ($125.68 to $125.44). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.